Prevalence and clinicopathological associations of HER2 expression in non-small cell lung cancer: a retrospective study in Jordanian patients

• Hauptverfasser: Ola Abu Al Karsaneh (Verfasst von), Arwa Al Anber (Verfasst von), Mohammad ALQudah (Verfasst von), Sahar Al-Mustafa (Verfasst von), Hussien AlMa'aitah (Verfasst von), Maher Sughayer (Verfasst von)
• Format: Buch
• Veröffentlicht: BMC, 2023-06-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Abstract Background Human epidermal growth factor receptor 2 (HER2), a promising therapeutic target, can be mutated, amplified, or overexpressed in different malignancies, including non-small cell lung cancer (NSCLC). Although these alterations showed adverse prognostic effects in many cancers, thei...